Less Ads, More Data, More Tools Register for FREE

Pin to quick picksColefax Grp. Regulatory News (CFX)

Share Price Information for Colefax Grp. (CFX)

Share Price is delayed by 15 minutes
Get Live Data
1,415.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 10.00 (0.709%)
Market Cap: £73.09m
CFX Live PriceLast checked at - London Stock Exchange

Intraday Colefax Grp. Share Chart

Tender Offer

27 Jan 2014 07:00

RNS Number : 5209Y
Colefax Group PLC
27 January 2014
 



THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, THE UNITED STATES OF AMERICA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

 

 

CFX

Colefax Group plc

("Colefax" or the "Company")

Tender Offer

Colefax today announces a proposed tender offer to buy up to approximately £4.4 million of ordinary shares of 10 pence each in the capital of the Company, representing 9 per cent. of the issued share capital of the Company. The Tender Offer is being implemented under the authority granted by Shareholders at the Company's Annual General Meeting held on 11 September 2012.

 

The Company has engaged Peel Hunt to implement the Tender Offer. Pursuant to the Tender Offer, Peel Hunt will purchase, as principal, up to a maximum of approximately 1.1 million Shares (being 9 per cent. of the Company's issued ordinary share capital).

 

A circular providing more information in relation to the Tender Offer and setting out the formal terms and conditions of the Tender Offer and Repurchase Agreement is expected to be posted to Eligible Shareholders (see below for definition) today.

 

Defined terms in this announcement are as those set out in the Circular.

 

Outline of the Tender Offer

 

The Tender Offer is being made at the lower of (i) 400 pence per Share; or (ii) 105 per cent. of the average closing mid-market price per Share as derived from the London Stock Exchange Daily Official List over the five business days immediately preceding 11 February 2014.

In accordance with the terms and conditions of the Repurchase Agreement, the Company has granted to Peel Hunt a put option under which Peel Hunt may require the Company to purchase, at the Tender Price, the Shares purchased by Peel Hunt pursuant to the Tender Offer. All of the Shares purchased by the Company pursuant to the Repurchase Agreement would be cancelled.

The purchase of Shares by the Company would be funded from available cash of the Company and would be paid out of the Company's distributable reserves. If the Tender Offer is taken up in full and the associated Repurchase is completed in full, the Company's distributable reserves would be reduced by the size of the Tender Offer.

 

The Company's issued ordinary share capital will be reduced to approximately 11.2 million Shares, assuming that: (i) the Tender Offer is taken up in full; (ii) the Repurchase Agreement is completed; and (iii) there is no change to the Company's issued ordinary share capital after 27 January 2014.

The Tender Offer is open to all shareholders on the Company's register of members at close of business on 7 February 2014 (the "Record Date") and who do not have a registered address in the United States of America, Canada, Australia or Japan ("Eligible Shareholders"). Peel Hunt, however, reserve the right, at their sole discretion, to extend the Tender Offer to shareholders that are not Eligible Shareholders where such extension will not constitute or give rise to a breach of applicable securities or other legal or regulatory requirements.

 

The Tender Offer is for up to 9% per cent. of the Company's issued share capital. Under the Tender Offer, each Eligible Shareholder is entitled to have up to 9% per cent. of his or her shareholding purchased by Peel Hunt at the Tender Price (the "Basic Entitlement"). Eligible Shareholders will be able to decide whether to tender none, some or all of their Shares within the overall limits of the Tender Offer. Tenders in excess of the Eligible Shareholder's Basic Entitlement will only be accepted to the extent that other Eligible Shareholders tender less than their Basic Entitlement or do not tender any Shares and will, if necessary, be scaled back on a pro rata basis (save for tenders from Eligible Shareholders who hold less than 1,000 Shares, whose tender will be accepted in full subject to there being capacity to purchase those Shares in accordance with the terms of the Tender Offer).

 

The Tender Offer is being made at a premium to the closing mid-market price on 24 January 2014 of 13.5 per cent.

 

Eligible Shareholders do not have to tender any Shares but, once submitted, a tender offer application form is irrevocable and cannot be withdrawn. Eligible Shareholders should note that, once tendered, Shares may not be sold, transferred, charged or otherwise disposed of.

 

The following Directors have informed the Company that they and their connected persons intend to tender the following number of Shares into the Tender Offer:

 

David Green

401,297

Rob Barker

23,013

Key Hall

18,135

Wendy Nicholls

48,776

 

In each case acceptance by the Company of an application under the Tender Offer in excess of 9% of the applicant's holding is subject to there being capacity to purchase those Shares in accordance with the terms of the Tender Offer.

 

Background to and reasons for the Tender Offer

 

The Company has built up distributable reserves of approximately £7.2 million and in line with the previous intention indicated by the Board, rather than buying back Shares on an ad hoc basis when they become available through the market, it would be appropriate to offer all Eligible Shareholders the opportunity to realise some of their investment in the Company by means of the Tender Offer.

 

A copy of the Circular has been submitted to the UK Listing Authority's National Storage Mechanism and will shortly be available at www.hemscott.com/nsm.do.

 

Full details of the Tender Offer are contained in the Circular which will shortly be available on the Company's investor relations website http://www.colefaxgroupplc.com/.

 

 

For further information:

 

Colefax Group plc

David Green, Chairman

Robert Barker, Finance Director

 

Tel: 020 7318 6000

Peel Hunt LLP

(NOMAD & Broker)

Dan Webster

Richard Brown

Matthew Armitt

 

 

Tel: 020 7418 8900

Biddicks

Katie Tzouliadis

Deborah Walter

 

Tel: 020 3178 6378

Peel Hunt LLP are acting for Colefax in relation to the Tender Offer and no one else and will not be responsible to anyone other than Colefax for providing the protections afforded to the customers of Peel Hunt LLP nor for providing any advice in relation to the Tender Offer.

This announcement does not constitute, or form part of, any offer for or invitation to sell or purchase any securities, or any solicitation of any offer for securities in any jurisdiction. Any acceptance or other response to the Tender Offer should be made only on the basis of information contained in or referred to in the Circular which will shortly be available on the Company's investor relations website http://www.colefaxgroupplc.com. The Circular will contain important information, including the full terms and conditions of the Tender Offer and how it may be accepted, which shareholders are urged to read carefully.

The Tender Offer is not being made in or into, and is not capable of acceptance in or from, The United States of America, Canada, Australia or Japan. Custodians, nominees and trustees should observe these restrictions and should not send or distribute documents in or into the United States of America, Canada, Australia or Japan.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TENEAEFLALELEAF
Date   Source Headline
23rd Sep 20212:49 pmRNSResult of AGM
23rd Sep 20217:00 amRNSAGM Statement
16th Sep 20212:57 pmRNSDirector/PDMR Share Dealings
14th Sep 20217:00 amRNSResult of Tender Offer
20th Aug 20217:00 amRNSAnnouncement of Tender Offer & Posting of Circular
12th Aug 20217:00 amRNSPreliminary Results
26th Apr 202112:39 pmRNSDirector/PDMR Shareholding
16th Mar 20215:49 pmRNSDirector/PDMR Shareholding
27th Jan 20217:00 amRNSInterim Results
19th Oct 20205:17 pmRNSResult of AGM
19th Oct 20207:00 amRNSAGM Statement
14th Sep 20207:00 amRNSFinal Results
23rd Mar 20207:00 amRNSCOVID-19 Impact and Interim Dividend Cancellation
25th Feb 20202:55 pmRNSHolding(s) in Company
28th Jan 20207:00 amRNSInterim Results
18th Sep 20192:14 pmRNSResult of AGM
18th Sep 20197:00 amRNSAGM Statement
23rd Jul 20197:00 amRNSPreliminary Results
7th May 20195:45 pmRNSHolding(s) in Company
1st May 20195:01 pmRNSDirector/PDMR Shareholding
30th Apr 201911:48 amRNSHolding(s) in Company
26th Apr 20197:00 amRNSResult of Tender Offer
9th Apr 20197:00 amRNSTender Offer
29th Jan 20197:00 amRNSHalf Year Results
13th Sep 20183:59 pmRNSResult of AGM
13th Sep 20187:00 amRNSAGM Statement
26th Jul 20187:00 amRNSPreliminary Results
9th Feb 20184:41 pmRNSHolding(s) in Company
9th Feb 201810:42 amRNSHolding(s) in Company
8th Feb 20183:58 pmRNSDirector/PDMR Shareholding
8th Feb 20183:56 pmRNSPurchase of Own Securities
29th Jan 20187:00 amRNSHalf-year Results
24th Nov 20172:12 pmRNSDirector/PDMR Shareholding
14th Sep 20175:49 pmRNSResult of AGM & GM
14th Sep 20177:00 amRNSAGM Statement
21st Aug 20174:17 pmRNSNotice of EGM and Posting of Annual Report
25th Jul 20177:00 amRNSFinal Results
10th May 20172:05 pmRNSHolding(s) in Company
24th Jan 20177:00 amRNSHalf Year Results
28th Sep 20167:00 amRNSHolding(s) in Company
15th Sep 20161:08 pmRNSResult of AGM
15th Sep 20167:00 amRNSAGM Statement
28th Jul 201611:52 amRNSPurchase of Own Securities
26th Jul 20167:00 amRNSPreliminary Results
18th May 20169:26 amRNSDirector/PDMR Shareholding
16th May 20165:16 pmRNSHolding(s) in Company
16th May 20165:10 pmRNSHolding(s) in Company
13th May 20164:49 pmRNSPurchase of Own Securities
22nd Apr 20161:48 pmRNSChange of Registered Office
4th Apr 20169:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.